SMAD4 levels and allelic imbalance in 18q21 in colorectal cancer [1]

Clinical Cancer Research

Volumn 12, Issue 5, 2006, Pages 1654-

  Watanabe, Toshiaki ^a   Kanazawa, Takamitsu ^a   Kazama, Yoshihiro ^a   Tanaka, Junichiro ^a   Tanaka, Toshiaki ^a   Ishihara, Soichiro ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD4 PROTEIN; FLUOROURACIL; SMAD4 PROTEIN, HUMAN; TUMOR MARKER;

ALLELIC IMBALANCE; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 18Q; COLORECTAL CANCER; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; CANCER STAGING; DIAGNOSTIC VALUE; HETEROZYGOSITY; CHROMOSOME 18; COLORECTAL TUMOR; GENETICS; METABOLISM; NOTE; SURVIVAL RATE;

ALLELIC IMBALANCE; CHROMOSOMES, HUMAN, PAIR 18; COLORECTAL NEOPLASMS; HUMANS; SMAD4 PROTEIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33645093698     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2322     Document Type: Letter

References (4)

1. Alhopuro P, Alazzouzi H, Sammalkorpi H, et al. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res 2005;11:6311-6.
2. Watanabe T, Wu TT, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-206.
3. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
4. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998;16:427-33.